ArticleTropical animal health and production2021
Chronic incurable mastitis in sheep: prevalence, identification of predisposing factors, and genotyping of fungal causative species using PCR-RFLP.
Article in Tropical animal health and production, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
3 citing papers in PubMed, 6 citations in OpenAlex.
- An update on clinically relevant, rare, and emergingClinical microbiology reviews · 2025Review
- Multilocus Sequence Typing and Antifungal Susceptibility ofFrontiers in veterinary science · 2022Article
- Subclinical Mastitis in Selected Bovine Dairy Herds in North Upper Egypt: Assessment of Prevalence, Causative Bacterial Pathogens, Antimicrobial Resistance and Virulence-Associated Genes.Microorganisms · 2021Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors at 2 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Mycotic mastitis is a neglected problem type of incurable chronic mastitis in sheep flock of many countries which associated with wide economic burden. In the current study, a total of 600 ewes at Menofia governorate, Egypt, were subjected to clinical and molecular examination using PCR-RFLP to estimate the prevalence of chronic mycotic mastitis and identify the causative agent. A structured questionnaire is distributed to shepherds in the study area to identify the risky behavioral practices being followed and lead to increase the prevalence of mycotic mastitis cases. The results showed that out of 600 ewes examined, 150 showed clinical signs of mastitis (25%). A total of 25 ewes with clinical mastitis did not respond to antibiotic treatment for long time and suffered from mycotic mastitis (16.7%, CI 11.1-23.6%). A total of 31 fungal isolates were identified: 14 yeast spp., Candida albicans, Candida parapasilosis, Candida rugosa, and Saccharomyces spp. and 17 mold spp., Alternaria spp., and Fusarium spp. Results showed also the widespread of risky practices among shepherds which could be responsible for the increase the prevalence of mycotic mastitis among ewes in the study area including presenting of decayed food to sheep, uncontrolled usage of antibiotics for mastitis treatment, lack of usage of antiseptics, and keeping of chronic infected animals in flocks for breeding. In conclusions, using of specific ITS1 and ITS4 primer sets with PCR-RFLP technique provided a suitable method for rapid identification and genotyping of Candida spp., Scaccharomyces, Alternaria, and Fusarium vertolliodes isolated from chronic mastitis in sheep. Furthermore, this study is considered up to our knowledge one of scarce estimates available on mycotic mastitis in sheep flocks in Egypt. Mycotic mastitis existed at higher prevalence estimates in the study area and educational campaigns to shepherds are much required to increase their awareness on the threat of risky of behaviors responsible for spread of the disease among their animals.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.